The Niche - Knoepfler lab stem cell blog

Guillaume Levrier CRISPR Consensus Meeting

Levrier guest post on CRISPR Consensus Meeting – “we all must get involved in this debate”

November 11, 2019 Paul Knoepfler 0

By Guillaume Levrier Human germline editing has been done before. It will be done again in the future, as it is relatively easy to perform. No mechanism with the de facto ability to prevent it from being organized has yet […]

Cool Cat iPS cells & other notable stem cell pubs/news

November 9, 2019 Paul Knoepfler 0

Once or twice a month I do a post on notable stem cell publications and news, which often but not always include research on iPS cells. It’s sort of a recommended reads kind of post, but I often include one […]

R3 Stem Cell still raises red flags for me after FDA letter including do one-get one meeting

November 6, 2019 Paul Knoepfler 3

Back in May, the FDA cautioned a stem cell clinic firm called R3 Stem Cell and its leader David Greene about what they were doing. Importantly, the agency indicated that some of R3’s stem cells may be unapproved drug products. While […]

Critical new piece on MD Stem Cells purported Right To Try program: let’s dig into it

November 3, 2019 Paul Knoepfler 3

I’ve been concerned about a stem cell group called MD Stem Cells for many years. Now it comes under more scrutiny from a new must-read piece by Donna Young over at S&P Global. Young’s article reports a puzzling, purported right-to-try […]

Bad Batch podcast is must listen for stem cell community

October 30, 2019 Paul Knoepfler 2

I’m relatively new to podcasts, but am enjoying a new stem cell-focused one called Bad Batch by medical journalist Laura Beil, which I’ve been listening to in the car as I commute. I just finished episode three. I’m curious to […]

The mission of the Knoepfler Lab Blog here at UC Davis School of Medicine is to build stem cell bridges to new treatments and cures through education, outreach, and science.

I encourage readers of this blog to make comments.

There are some rules and key considerations for ipscell.com governing the comments to keep in mind.

Comments will be moderated by a really busy human being so they may not appear right away, particularly if they are long and/or contain allegations against people or companies, or express inflammatory opinions in which case they may take up to a day or longer to appear or may never appear.
Comments cannot include personal attacks.
Commenters should avoid being libelous to a person or corporation.
Commenters must use a valid email address.
Commenters generally cannot promote a specific unproven stem cell clinic or physician even by implication.
Commenters are solely responsible for the content of their comments.
I generally do not post comments written by parties referring to other parties who are both involved in an ongoing or pending legal dispute with each other such as litigation. Exceptions to this may be allowed for comments on a blog post that has a topic focused specifically on said legal disputes.
Commenters cannot give medical advice.
Consumers posting comments regarding their opinions of medical treatment they received are solely responsible for that content and readers should understand that such comments reflect opinions, not facts.
Commenters who violate this policy with their submitted comments may temporarily or permanently lose the right to make comments.

By submitting your comment for potential posting on this blog you agree that the comment may be either edited or not posted at all at the blog's discretion if there is concern about non-compliance with this comment policy.

Disclosures

The views expressed on this blog in posts are my own and do not reflect the views of my employer, UC Davis.

I have no financial interests in any stem cell companies or patents in that area.

No material on this website should be considered medical advice and all medical decisions should be discussed with your personal physician first.